Published Date: 13 Mar 2023
The report found that among pediatric patients infected with COVID-19 and influenza, most hospitalized or deceased patients had underlying conditions and were unvaccinated with fever all over.
Read Full NewsEurope will need to rethink how it values and pays for innovative medicines or risk losing manufacturing investments and clinical trials, the head of Europe's pharmaceutical industry lobby said.
Patients, doctors, and other healthcare professionals who spoke with KFF Health News say the effort has created confusion, errors, long wait times, and stress.
Research on creatine supplementation has moved from the gym to the brain lab, leading neurologist Heidi Moawad to review the data on creatine’s potential for improving cognitive health.
Patients with MASLD often underreport alcohol use and even modest intake can block improvement. Drs VanWagner and Ajmera share practical tools to quantify intake, spot MetALD, and counsel patients effectively.
MASLD is a silent condition and labs may look normal. Drs VanWagner and Shubrook walk through who to screen, how to use FIB-4, and when primary care can manage MASLD without a specialist.
Palbociclib is now the first CDK4/6 inhibitor approved for metastatic disease regardless of HER2 status.
Mirvetuximab has come up short in the first randomized trial testing an antibody-drug conjugate plus standard carboplatin for patients with platinum-sensitive ovarian cancer.
1.
A paper strip test might enable the early detection of cancer.
2.
New drug combination shows particularly good results in patients with HPV-negative head and neck cancer
3.
In NSCLC, subcutaneous Lazertinib + Amivantamab Dosing Is Not Worse Than IV Dosing.
4.
ACS Guidelines Expand Lung Cancer Screening Eligibility -- Is That a Good Thing?
5.
Which Salvage Therapy Is Best for Recurrent Prostate Cancer?
1.
Omega-3 Fatty Acids as Molecular Adjuvants Against Chemoresistance in Breast Cancer
2.
A Closer Look at White Blood Cells in Urine: Uncovering the Causes and Treatments
3.
Trends in Incidence, Care, and Surgery for Medullary Thyroid Cancer: A Review
4.
Amivantamab Plus Chemotherapy Outperforms Standard Care in Post-Osimertinib NSCLC
5.
Citizen-Centered Digital Health Navigation Systems: Advancing Patient Engagement and Optimizing Healthcare Delivery
1.
Asian Symposium on Advancement in Hematology and Oncology
2.
Asian Symposium on Advancement in Hematology and Oncology
3.
International Cancer Conference
4.
Asian Symposium on Advancement in Hematology and Oncology
5.
International Lung Cancer Congress®
1.
Pazopanib Takes Center Stage in Managing Renal Cell Carcinoma - Part I
2.
A Comprehensive Guide to First Line Management of ALK Positive Lung Cancer - Part IV
3.
Breaking Ground: ALK-Positive Lung Cancer Front-Line Management - Part I
4.
An Eagles View - Evidence-based Discussion on Iron Deficiency Anemia- Panel Discussion
5.
Pazopanib: A Game-Changer in Managing Advanced Renal Cell Carcinoma - Part IV
© Copyright 2026 Hidoc Dr. Inc.
Terms & Conditions - LLP | Inc. | Privacy Policy - LLP | Inc. | Account Deactivation